Looks like you clickedhttps://www.urotoday.com/conference-highlights/asco-2019-annual-meeting/asco-2019-prostate-cancer/113081-asco-2019-abiraterone-acetate-plus-prednisone-without-continuing-lhrh-therapy-in-patients-with-metastatic-chemotherapy-naive-castrations-resistant-prostate-cancer-results-fro
If you do not want to visit that page, you can close this browser tab.
